Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.
The current price of MDRSF is $115 USD — it has increased by +12.73% in the past 24 hours. Watch Medartis stock price performance more closely on the chart.
What is Medartis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medartis stocks are traded under the ticker MDRSF.
What is Medartis market cap?▼
Today Medartis has the market capitalization of 1.57B
When is the next Medartis earnings date?▼
Medartis is going to release the next earnings report on August 18, 2026.
What is Medartis revenue for the last year?▼
Medartis revenue for the last year amounts to 496.67M USD.
What is Medartis net income for the last year?▼
MDRSF net income for the last year is 7.8M USD.
How many employees does Medartis have?▼
As of April 05, 2026, the company has 816 employees.
In which sector is Medartis located?▼
Medartis operates in the Health Care sector.
When did Medartis complete a stock split?▼
The last stock split for Medartis was on June 01, 2018 with a ratio of 1:10.